Business Context and Reporting Period
Company: Daré Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 7, 2019
Reporting Period: Single event date (January 7, 2019)
Business Context: The registrant is an emerging growth company incorporated in Delaware. This filing serves to distribute a corporate presentation regarding the company and its product candidates to investors and securities analysts.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate presentation rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within the text of this Form 8-K. The primary event is the release of a corporate presentation (Exhibit 99.1) dated January 7, 2019, which is incorporated by reference.
Guidance, Outlook, and Risks
Management Commentary: The company intends to use the attached presentation in meetings with investors and analysts commencing on the filing date.
Guidance and Risks: The filing text does not contain specific forward-looking guidance, risk factors, or contingencies. These details are presumed to be contained within the referenced Exhibit 99.1 presentation, the content of which is not included in the provided text.
Investor Verification Checklist
- Review the full content of Exhibit 99.1 (Corporate Presentation) for specific product candidate updates and financial projections.
- Verify the company's status as an emerging growth company and any election regarding extended transition periods for accounting standards.
- Confirm the date and distribution scope of the investor meetings referenced in Item 8.01.